Paper of the Month January 2016
Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose
J Infect Dis. 2016 Jan 21. pii: jiv748. [Epub ahead of print]
Bruce MG et al Arctic Investigations program, Division of Preparedness and Emerging Infections, National Center from Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention
The duration of protection in children and adults resulting from hepatitis B vaccination is unknown. In 1981, we immunized a cohort of 1578 Alaska native adults and children from 15 Alaska communities aged >= 6 months using 3 does of plasma-derived hepatitis B vaccine.